SEC Form 4 · accession 0001179110-17-011859
AMAG PHARMACEUTICALS INC. · AMAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Vittiglio
Officer — SVP, General Counsel
Period of report
Aug 24, 2017
Accepted (ET)
Aug 28, 2017 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 24, 2017 | F | 1,633 | $17.50 | D | 34,754 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 5,000 restricted stock units on August 24, 2017. 1,633 shares were withheld to satisfy the reporting person's applicable tax obligations.